Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Adjuvant chemotherapy and radiotherapy in the treatment of non-small cell lung cancer (NSCLC)..
J Thorac Dis. 5 Suppl 4, S371-7.
(2013). Advanced bronchoscopic techniques in diagnosis and staging of lung cancer..
J Thorac Dis. 5 Suppl 4, S359-70.
(2013). Cell viability of fibroblasts to pifenidone and sirolimus: a future concept for drug eluting stents..
Int J Pharm. 466(1-2), 38-43.
(2014). Cone Beam Computertomography (CBCT) in Interventional Chest Medicine - High Feasibility for Endobronchial Realtime Navigation..
J Cancer. 5(3), 231-41.
(2014). Could Somatostatin Enhance the Outcomes of Chemotherapeutic Treatment in SCLC?.
J Cancer. 6(4), 360-6.
(2015). DDMC-p53 gene therapy with or without cisplatin and microwave ablation..
Onco Targets Ther. 8, 1165-73.
(2015). Defense mechanisms of the respiratory system and aerosol production systems..
Med Chem. 10(2), 123-36.
(2014). Defining the role of tyrosine kinase inhibitors in early stage non-small cell lung cancer..
J Cancer. 6(6), 568-74.
(2015). "Denervation" of autonomous nervous system in idiopathic pulmonary arterial hypertension by low-dose radiation: a case report with an unexpected outcome..
Ther Clin Risk Manag. 10, 207-15.
(2014). Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology..
Future Oncol. 9(4), 505-25.
(2013). EGFR-TKIs in adjuvant treatment of lung cancer: to give or not to give?.
Onco Targets Ther. 8, 2915-21.
(2015). Endometriosis of the lung: report of a case and literature review..
Eur J Med Res. 18, 13.
(2013). Establishing the optimal nebulization system for paclitaxel, docetaxel, cisplatin, carboplatin and gemcitabine: back to drawing the residual cup..
Int J Pharm. 453(2), 480-7.
(2013). Experimentation with aerosol bonsetan, pirfenidone, treprostinil and sidenafil..
J Thorac Dis. 6(10), 1411-9.
(2014). Experimentation with inhaled bronchodilators and corticosteroids..
Int J Pharm. 461(1-2), 411-8.
(2014). Following the crumbs: from tissue samples, to pharmacogenomics, to NSCLC therapy..
Transl Lung Cancer Res. 2(4), 256-8.
(2013). Further experimentation of inhaled; LANTUS, ACTRAPID and HUMULIN with todays' production systems..
Int J Pharm. 458(1), 39-47.
(2013). Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a phase II, randomized study..
Drug Des Devel Ther. 7, 611-7.
(2013). Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients..
Future Oncol. 9(9), 1307-13.
(2013). Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer..
Future Oncol. 9(8), 1171-94.
(2013). Interleukin-6 cytokine: a multifunctional glycoprotein for cancer..
Immunome Res. 9(62), 16535.
(2013). Internal mouthpiece designs as a future perspective for enhanced aerosol deposition. Comparative results for aerosol chemotherapy and aerosol antibiotics..
Int J Pharm. 456(2), 325-31.
(2013). Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies..
Drug Des Devel Ther. 7, 571-83.
(2013). Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis..
J Mol Genet Med. 7, 65.
(2013). Malignant pleural effusion and algorithm management..
J Thorac Dis. 5 Suppl 4, S413-9.
(2013).